Date: Wednesday 19th June 2019
Time: 15:30 - 16:30
Venue: Clinical School Seminar Lecture Theatre 2, Cambridge Biomedical Campus, Cambridge CB2 0SP
Jennifer Kehlet Barton, PhD, Professor, Biomedical Engineering, University of Arizona
Talk Abstract: Optical imaging techniques have been shown to be highly sensitive to early stages of cancer. We have examined techniques including optical coherence tomography, fluorescence imaging, and multiphoton imaging in mouse models of ovarian cancer as well as human samples of uterine tube and ovary. These studies suggest that ovarian cancer is detectable at microscopic as well as macroscopic scales. To implement early detection in vivo, a method of reaching the ovaries and fallopian tubes in a minimally invasive fashion must be found. We are developing endoscopes which travel a variety of paths through the female reproductive system, and incorporate one or more of the optical modalities.
Speaker Bio: Jennifer Barton received the BS and MS degrees in electrical engineering from the University of Texas at Austin and University of California Irvine, respectively. She worked for McDonnell Douglas (now Boeing) on the Space Station program before returning to The University of Texas at Austin to obtain the PhD in Biomedical Engineering in 1998. She is currently Professor of Biomedical Engineering, and Director of the BIO5 Institute, a collaborative research institute dedicated to solving complex biology-based problems affecting humanity.
Barton develops miniature endoscopes that combine multiple optical imaging techniques, particularly optical coherence tomography and fluorescence spectroscopy. She evaluates the suitability of these endoscopic techniques for detecting early cancer development in patients and pre-clinical models. She has a particular interest in the early detection of ovarian cancer, the most deadly gynecological malignancy. Additionally, her research into light-tissue interaction and dynamic optical properties of blood laid the groundwork for a novel therapeutic laser to treat disorders of the skin’s blood vessels. She is a fellow of SPIE- the International Optics Society, and a fellow of the American Institute for Medical and Biological Engineering.
Date: Monday 8th July 2019
Time: 17:00 - 19:00
Venue: Trinity College, Fellows' Bowling Green, Trinity Street, Cambridge CB2 1TQ
Please join us to celebrate the ongoing achievements of the CRUK Cambridge Centre Early Detection Programme and to thank you for your support.
Light refreshments will be served, click here to register for this event.
Date: Monday 15th July 2019 - Thursday 18th July 2019
Venue: Robinson College, Grange Road, Cambridge CB3 9AN, UK
We present the first international summer school on discovery and development of diagnostics for the early detection of cancer. The summer school is aimed at those who are developing new technologies and interventions for the early detection of cancer and those who are interested in exploring this rapidly expanding and exciting field and is open to academic, corporate and student delegates.
Please click here for more information about the International Summer School.
Date: Every Thursday, starting on 18 April
Time: 09:30 - 10:30
Venue: Clinical School Lecture Theatre 2 These talks aim to give a general introduction to cancer biology and medicine and all students and staff are welcome to attend.
Thursday 18 April: Dr Charlotte Coles, Department of Oncology. Breast cancer - demographics, presentation, diagnosis and patient pathway
Thursday 25 April: Dr Jason Carroll & Dr Walid Khaled, CRUK Cambridge Institute & Department of Pharmacology. The role of transcription factors in cancer
Thursday 2 May: Dr James Brenton & Professor Paul Pharoah, CRUK Cambridge Institute & Department of Public Health and Primary Care Biological and Clinical Features of High Grade Serous Ovarian Cancer
Thursday 9 May: Dr Grant Stewart, Department of Surgery. Kidney cancer: the most lethal urological malignancy
Thursday 16 May: Professor Paul Pharoah, Department of Public Health and Primary Care. Epidemiology of Ovarian Cancer
Thursday 23 May: Mr Vincent Gnanapragasam, Department of Surgery. The clinical and biological basis of prostate cancer - from diagnosis to personalised therapy
Thursday 30 May: Mr Thomas Santarius, Department of Neurosciences. Brain tumours - demographics, presentation, diagnosis, patient pathways
Thursday 6 June: Dr Harry Bulstrode, Department of Clinical Neuroscience. Clinical Treatment and Cancer Stem Cell Biology in Malignant Glioma
Thursday 13 June: Dr Amos Burke, Department of Paediatric Haematology, Oncology and Palliative Care. Paediatric malignancies: an overview
Thursday 20 June: Dr Sam Behjati, Department of Paediatrics and WTSI. The Childhood Cancer Genome
Thursday 27 June: Dr Marc de la Roche, Department of Biochemistry. Cellular signalling networks in colon cancer and the models to study them - a basic research perspective
Thursday 4 July: Dr Robert Rintoul & Dr Frank McCaughan, CRUK Cambridge Institute & Department of Biochemistry. Lung Cancer. Part 1. Patient pathway and Intervention. Part 2. Lung Cancer: Futurescape
Thursday 11 July: Mr Raaj Praseedom, Cambridge University Hospitals. Diagnostics and patient pathways in pancreatic cancer
Thursday 18 July: Dr Barry Davies, AstraZeneca. The AKT inhibitor Capivasertib (AZD5363): from discovery to clinical proof of concept
Thursday 25 July: Dr Matthew Murray, Department of Pathology. MicroRNAs as circulating biomarkers in cancer
Date: Tuesday 24 - Thursday 26th September 2019
Venue: Frances C. Arrillaga Alumni Center, Stanford, California
Canary Center at Stanford, Cancer Research UK and the OHSU Knight Cancer Institute, present the Early Detection of Cancer Conference series. The annual Conference brings together experts in early detection from multiple disciplines to share ground breaking research and progress in the field.
The Conference is part of a long-term commitment to invest in early detection research, to understand the biology behind early stage cancers, find new detection and screening methods and enhance uptake and accuracy of screening.
Date: Tuesday 15 - Thursday 17th October 2019
Venue: Radisson Blu Portman, Marylebone, London
The Cancer Research UK–AACR Joint Conference on Engineering and Physical Sciences in Oncology is taking place in London this autumn where alliances between cancer researchers and leading scientists from engineering and physical sciences backgrounds will be sparked.
The multidisciplinary programme will explore new ways to transform our understanding of biology and to better detect and treat cancer, enabling expert speakers to address some of the toughest challenges in cancer research from a variety of perspectives. You’ll have ample opportunity to interact with leaders in their field, while sessions will equip you with valuable insights into building effective alliances across disciplines.
Our programme leader, Dr Sarah Bohndiek, will be speaking in the ‘state-of-the-art cancer detection technology’ session. To see the full conference programme or to register, please click here.